Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified MRC UKALL XII/ECOG E2993 for Young Adult ALL
NCT02660762Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2016
- Primary completion
- Jan 2019
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02660762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660762.